<DOC>
	<DOC>NCT01359917</DOC>
	<brief_summary>The hypotheses of this study were that: 1. HIV lipodystrophy is associated with psychological morbidity relating to body image, anxiety and depression. 2. Treatment of HIV lipodystrophy using autologous fat transfer, polylactic acid or Bio-alcamid, is associated with an improvement in psychological morbidity and anatomical volume of treated areas. 3. The DI3D system is a valid and reproducible method of recording and measuring facial 3-D volume.</brief_summary>
	<brief_title>Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome</brief_title>
	<detailed_description>as above</detailed_description>
	<mesh_term>Lipodystrophy</mesh_term>
	<mesh_term>HIV-Associated Lipodystrophy Syndrome</mesh_term>
	<criteria>HIV facial lipoatrophy concurrent antiretrovirals known psychological disorder skin allergies significant medical problems precluding anaesthesia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2006</verification_date>
</DOC>